Health Law & Policy

Fewer state Medicaid programs are restricting access to hepatitis C medicines, but hurdles remain

excerpt thumb

This article was original written by Ed Silverman and published by STAT News on May 19, 2021.  Over the past few years, state Medicaid programs have done a better job of disclosing information about access to expensive hepatitis C medicines […]

New Report Shows Discriminatory Sobriety Restrictions Undermine Public Health Efforts to Eliminate Hepatitis C

excerpt thumb

The Hepatitis C: State of Medicaid Access National Progress Report shows that hepatitis C patients have better access to treatment, but that sobriety restrictions remain particularly harmful amid the ongoing opioid epidemic. The Center for Health Law and Policy Innovation […]

Plaintiffs Urge HHS to Fully Reverse Trump-Era Healthcare Discrimination Rule

excerpt thumb

Encouraged by Biden-Harris Administration’s Initial Steps to Rescind Trump “Rollback Rule,” Advocates Urge HHS to Take Further Steps to Reverse Regulation, Address the Harms It Has Caused Trump-Era “Rollback Rule” Undermines ACA’s Nondiscrimination Protections for LGBTQ+ People, Patients Seeking Reproductive […]

Michigan Improves Access to Hepatitis C Treatment for Medicaid and Healthy Michigan Plan Patients

excerpt thumb

The Wolverine state removed prior authorization requirements for a preferred hepatitis C medication, increasing access to hepatitis C treatment for more Michiganders. The Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis […]

Drug-price negotiation proposals could clear Senate rules

excerpt thumb

Originally written by Erin Durkin and posted on National Journal on April 1, 2021. Policy experts say measures allowing government negotiation of drug prices for Medicare could get past Senate restrictions. Democrats may be teeing up provisions to let the […]

Expert panel issues recommendations for addressing cancer inequities

excerpt thumb

Originally posted on Mirage News on March 29, 2021 Recommendations stem from conference of National Cancer Institute and Comprehensive Cancer Center representatives Recommendations call for enhanced community partnerships and higher priority for community-outreach efforts New recommendations co-developed by Dana-Farber Cancer […]

Harvard Legal Experts Identify Pathways to Mainstream Produce Prescription Programs

excerpt thumb

A new policy strategy report from Harvard Law School’s Center for Health Law and Policy Innovation aims to scale up the provision of nutrition benefits in health care and food systems. Diet is a key driver of both poor health […]

Health Equity Journal Highlights Pathways for More Effective Outreach and Engagement in Comprehensive Cancer Centers

excerpt thumb

Health Equity recently published two journal articles co-authored by the Center for Health Law and Policy Innovation’s Sarah Downer, highlighting key findings and recommendations on community outreach and engagement efforts of the National Cancer Institute’s Comprehensive Cancer Centers. The titles […]

Senate Rules Loom over Medicaid Proposals

excerpt thumb

This article was originally written by Erin Durkin and published by National Journal on February 22, 2021. Although policy experts think the Medicaid provisions of the COVID-19 package will likely clear budget-reconciliation rules, nothing is guaranteed. House Democrats are aiming […]

Wisconsin and Indiana Remove Barrier to Hepatitis C Treatment for Medicaid Patients

excerpt thumb

This article was originally released by the National Viral Hepatitis Roundtable on February 22, 2021. The two midwestern states removed prior authorizations for first time hepatitis C treatment, increasing opportunities for 130,000 individuals to be treated and cured of hepatitis […]